Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Piribedil (Trivastan) is a dopamine D2 agonist, used in the treatment of Parkinson's disease.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
25 mg | 在庫あり | ¥ 12,000 | |||
50 mg | 在庫あり | ¥ 16,000 | |||
100 mg | 在庫あり | ¥ 21,000 | |||
200 mg | 在庫あり | ¥ 36,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,500 |
説明 | Piribedil (Trivastan) is a dopamine D2 agonist, used in the treatment of Parkinson's disease. |
ターゲット&IC50 | D2 receptor:6.9(pKi), α2C-adrenoceptor:7.2(pKi), α2A-adrenoceptor:7.1(pKi) |
別名 | EU-4200, Trivastan, ET-495, Trivastal |
分子量 | 298.34 |
分子式 | C16H18N4O2 |
CAS No. | 3605-01-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Chloroform: Soluble
DMSO: 54 mg/mL(181 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Piribedil 3605-01-4 Chromatin/Epigenetic GPCR/G Protein Neuroscience Adrenergic Receptor Dopamine Receptor Histone Methyltransferase EU-4200 dyskinesias THP-1 anti-leukemic Trivastan Inhibitor Beta Receptor MV4 EU 4200 EU4200 ET-495 Parkinson's leukemia ET495 MLL1 cancer ET 495 inhibit locomotor activity Trivastal inhibitor